State of New Jersey Common Pension Fund D Buys 10,389 Shares of Ventas, Inc. $VTR

State of New Jersey Common Pension Fund D boosted its stake in Ventas, Inc. (NYSE:VTR) by 2.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 386,686 shares of the real estate investment trust’s stock after purchasing an additional 10,389 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Ventas were worth $27,064,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Norges Bank bought a new position in shares of Ventas in the 2nd quarter worth $344,740,000. Vanguard Group Inc. grew its position in Ventas by 4.1% in the second quarter. Vanguard Group Inc. now owns 71,796,312 shares of the real estate investment trust’s stock worth $4,533,937,000 after acquiring an additional 2,854,751 shares in the last quarter. Citigroup Inc. increased its stake in Ventas by 451.9% in the second quarter. Citigroup Inc. now owns 2,316,344 shares of the real estate investment trust’s stock valued at $146,277,000 after acquiring an additional 1,896,627 shares during the last quarter. State Street Corp raised its position in Ventas by 5.2% during the second quarter. State Street Corp now owns 27,998,629 shares of the real estate investment trust’s stock valued at $1,781,267,000 after purchasing an additional 1,388,678 shares in the last quarter. Finally, Invesco Ltd. lifted its stake in Ventas by 36.1% during the second quarter. Invesco Ltd. now owns 4,812,970 shares of the real estate investment trust’s stock worth $303,939,000 after purchasing an additional 1,275,446 shares during the last quarter. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Ventas Stock Performance

NYSE:VTR opened at $85.15 on Monday. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.67 and a current ratio of 0.67. Ventas, Inc. has a fifty-two week low of $60.15 and a fifty-two week high of $87.20. The firm has a market cap of $40.44 billion, a PE ratio of 157.68, a price-to-earnings-growth ratio of 2.11 and a beta of 0.77. The business has a 50 day moving average price of $78.54 and a 200-day moving average price of $73.91.

Ventas (NYSE:VTR) last issued its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing the consensus estimate of $0.89 by ($0.74). The firm had revenue of ($1,229.71) million during the quarter, compared to analysts’ expectations of $1.53 billion. Ventas had a return on equity of 2.09% and a net margin of 4.31%.The firm’s quarterly revenue was up 21.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.81 earnings per share. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Equities research analysts predict that Ventas, Inc. will post 3.4 earnings per share for the current year.

Ventas Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. This is a positive change from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Tuesday, March 31st. Ventas’s payout ratio is currently 355.56%.

Analysts Set New Price Targets

Several equities analysts have recently commented on VTR shares. Wells Fargo & Company increased their price objective on Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. KeyCorp upped their target price on Ventas from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. UBS Group reissued a “neutral” rating and set a $85.00 price target on shares of Ventas in a research note on Monday, February 9th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $100.00 price objective on shares of Ventas in a research note on Monday, February 9th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $93.00 target price on shares of Ventas in a report on Monday, December 15th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $86.87.

Insider Activity

In other news, CFO Robert F. Probst sold 29,930 shares of Ventas stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $77.25, for a total value of $2,312,092.50. Following the sale, the chief financial officer directly owned 138,434 shares in the company, valued at approximately $10,694,026.50. This trade represents a 17.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Debra A. Cafaro sold 10,322 shares of the business’s stock in a transaction that occurred on Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the transaction, the chief executive officer directly owned 1,114,034 shares in the company, valued at $86,515,880.44. This trade represents a 0.92% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 91,106 shares of company stock valued at $7,331,603. Company insiders own 1.00% of the company’s stock.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.